• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人红细胞表面的静电和结构特性。3. 添加人血清白蛋白后的细胞电泳研究。

Electrostatic and structural properties of the surface of human erythrocytes. 3. Cell electrophoretical studies following addition of human serum albumin.

作者信息

Donath E, Steidel R

出版信息

Acta Biol Med Ger. 1980;39(2-3):207-15.

PMID:7424341
Abstract

It has been shown that human serum albumin (HSA) under physiological conditions does not affect the electrophoretical properties of human erythrocytes. In contrast, albumin at low ionic strengths and low pH-values progressively reduces the electrophoretical mobility up till a reversal of the erythrocytes' movement with simultaneous aggregation. Zero mobility is strongly ionic strength dependent; this property cannot be explained by the ionic strength dependence of the isoelectric point of HSA. It is concluded that the HSA is bound to the lipid matrix. This offers an explanation that the influence of HSA becomes electrophoretically demonstrable particularly at low ionic strengths. The identification limit of alterations induced by HSA corresponds to the physiological concentrations of HSA in blood.

摘要

研究表明,在生理条件下,人血清白蛋白(HSA)不会影响人红细胞的电泳特性。相比之下,在低离子强度和低pH值条件下,白蛋白会逐渐降低电泳迁移率,直至红细胞运动方向逆转并同时发生聚集。零迁移率强烈依赖于离子强度;这一特性无法用HSA等电点对离子强度的依赖性来解释。得出的结论是,HSA与脂质基质结合。这就解释了为什么HSA的影响在低离子强度下尤其在电泳中表现得明显。HSA诱导的变化的识别极限与血液中HSA的生理浓度相对应。

相似文献

1
Electrostatic and structural properties of the surface of human erythrocytes. 3. Cell electrophoretical studies following addition of human serum albumin.人红细胞表面的静电和结构特性。3. 添加人血清白蛋白后的细胞电泳研究。
Acta Biol Med Ger. 1980;39(2-3):207-15.
2
Adsorption of human serum albumin (HSA) onto colloidal TiO2 particles, Part I.人血清白蛋白(HSA)在胶体二氧化钛颗粒上的吸附,第一部分。
J Colloid Interface Sci. 2003 May 15;261(2):299-311. doi: 10.1016/S0021-9797(03)00029-8.
3
Influence of electrostatic interactions on the fibrillation process of human serum albumin.静电相互作用对人血清白蛋白纤维化过程的影响。
J Phys Chem B. 2009 Jul 30;113(30):10521-9. doi: 10.1021/jp902224d.
4
Separation of human serum albumin and human immunoglobulins using carrier phase ultrafiltration.
Biotechnol Prog. 2004 Jul-Aug;20(4):1103-12. doi: 10.1021/bp0343716.
5
[Inverse pH-dependent shape changes of erythrocytes in the presence of albumin].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1980;107(3):454-8.
6
Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine.用人类血清白蛋白(HSA)和肌酸功能化的金纳米颗粒的电泳表征
J Colloid Interface Sci. 2009 Apr 1;332(1):215-23. doi: 10.1016/j.jcis.2008.11.077. Epub 2009 Jan 19.
7
Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.人血清白蛋白(HSA)纳米颗粒:制备过程的可重复性及酶促降解动力学
Int J Pharm. 2008 Jan 22;347(1-2):109-17. doi: 10.1016/j.ijpharm.2007.06.028. Epub 2007 Jun 23.
8
Interaction of erythrocytes with human serum proteins. I. Analysis of the effect of pH and ionic strength of the medium.
J Hyg Epidemiol Microbiol Immunol. 1976;21(3):353-60.
9
Interaction of erythrocytes with human serum proteins. I. Analysis of the effect of pH and ionic strength of the medium.红细胞与人类血清蛋白的相互作用。I. 介质pH值和离子强度影响的分析
J Hyg Epidemiol Microbiol Immunol. 1976;21(3):353-60.
10
Influence of O(2)-carrying plasma hemoprotein "albumin-heme" on complement system and platelet activation in vitro and physiological responses to exchange transfusion.携带氧气的血浆血红蛋白“白蛋白-血红素”对体外补体系统和血小板活化的影响以及对换血疗法的生理反应。
J Biomed Mater Res A. 2007 Jun 15;81(4):821-6. doi: 10.1002/jbm.a.31016.

引用本文的文献

1
Electrophoretic mobility of human erythrocytes. On the applicability of the charged layer model.人类红细胞的电泳迁移率。关于带电层模型的适用性。
Biophys J. 1986 Feb;49(2):493-9. doi: 10.1016/S0006-3495(86)83659-1.